Verificando…
Traducido automáticamente. Dosis y advertencias: consulta el original en inglés. Leer en inglés
Inicio / Registrado en Nigeria / Trexip-TZ Tablets

Trexip-TZ Tablets

NAFDAC Reg. No. A4-6072 Estupefaciente

Registrado en NAFDAC. Registro activoAs of 1 November 2026 · synced automatically from official sources.
Producto
Trexip-TZ Tablets
Número NAFDAC
A4-6072
Principio activo
Ciprofloxacin (Ciprofloxacin Hydrochloride); Tinidazole
Dosis
500 mg; 600 mg
Forma
Tablet
Tamaño del envase
1 x 10's (in blister)
Fabricante
No Constan
Solicitante (titular)
Greenlife Pharmaceutical Limited
Approved
26 Jan 2023
Estado
Activo Ver en NAFDAC ↗
Registro válido hasta
25 Jan 2028
Alertas de la OMS
No se ha encontrado ninguno
Informes de la comunidad
Ninguno
Tiempos comprobados
0

Pero sobre el medicamento, Ciprofloxacin: uses, dosage and brands worldwide

Lo que encontramos

  • Trexip-TZ Tablets is on the NAFDAC register with an active registration (A4-6072). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generado automáticamente a partir del registro NAFDAC, QUIÉN alerta y los datos de la comunidad a partir de hoy. Este no es un consejo médico. Siga siempre a su médico o farmacéutico.

How to use Trexip-TZ Tablets

Lo que dice el prospecto oficial. Si te lo recetó un médico, sigue la receta. Si el prospecto de tu caja es distinto, manda el de tu caja.

Para quién es

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae *Efficacy for this organism was studied in fewer than 10 infections.

Cómo tomarlo y con qué frecuencia
  • Corneal Ulcers: The recommended dosage regimen
  • For the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day
  • On the second day, instill two drops in the affected eye hourly
  • On the third through the fourteenth day, place two drops in the affected eye every four hours
  • Treatment may be continued after 14 days if corneal re-epithelialisation has not occurred
  • Bacterial Conjunctivitis: The recommended dosage regimen
  • For the treatment of bacterial conjunctivitis is one or two drops instilled into the conjunctival sac(s) every two hours while awake for two days and one or two drops every four hours while awake for the next five days
Infancia
  • The safety and effectiveness of Ciprofloxacin ophthalmic solution 0.3% have been established in all ages
  • Use of Ciprofloxacin ophthalmic solution is supported by evidence from adequate and well controlled studies of Ciprofloxacin ophthalmic solution
  • In adults, children and neonates [ see Clinical Studies ]. …
Older adults

No overall differences in safety or effectiveness have been observed between elderly and younger patients.

While you are taking it

Do not touch dropper tip to any surface, as this may contaminate the solution.

Talk to a doctor first if
  • A history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use
  • A history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin
Medicines it may not mix with

Specific drug interaction studies have not been conducted with ophthalmic ciprofloxacin. However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, enhance the effects of the oral anticoagulant, warfarin, and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly.

Warnings

NOT FOR INJECTION INTO THE EYE. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolone therapy. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, tingling, pharyngeal or facial edema, dyspnea, urticaria, and itching. Only a few patients had a history of hypersensitivity reactions. Serious anaphylactic reactions require immediate emergency treatment with epinephrine and other resuscitation measures, including oxygen, intravenous fluids, intravenous antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated. …

Posibles efectos secundarios

The most frequently reported drug related adverse reaction was local burning or discomfort. In corneal ulcer studies with frequent administration of the drug, white crystalline precipitates were seen in approximately 17% of patients ( see Precautions ). Other reactions occurring in less than 10% of patients included lid margin crusting, crystals/scales, foreign body sensation, itching, conjunctival hyperemia and a bad taste following instillation. Additional events occurring in less than 1% of patients included corneal staining, keratopathy/keratitis, allergic reactions, lid edema, tearing, photophobia, corneal infiltrates, nausea and decreased vision. …

If you take too much

A topical overdose of ciprofloxacin Ophthalmic Solution may be flushed from the eye(s) with warm tap water.

Si olvidas una dosis

Tómala en cuanto te acuerdes, salvo que falte poco para la siguiente. En ese caso, sáltate la olvidada. Nunca tomes dos dosis a la vez para compensar. Revisa tu prospecto, porque algunos medicamentos son distintos.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2022-05-02.

Label for ciprofloxacin (ciprofloxacin hydrochloride) and tinidazole, the active ingredient registered with NAFDAC.

Check your pack of Trexip-TZ Tablets

Add the expiry date on your pack for a full Trust Score.

O haz fotos de la caja
Te quedan 3 verificaciones gratis hoy Fuentes oficiales: FDA de EE. UU. · EMA (UE) · NAFDAC · alertas de la OMS

About Trexip-TZ Tablets

What is in Trexip-TZ Tablets?

Trexip-TZ Tablets contains Ciprofloxacin (Ciprofloxacin Hydrochloride); Tinidazole (500 mg; 600 mg), as tablet, according to its NAFDAC registration record.

Is Trexip-TZ Tablets registered with NAFDAC?

Yes. Trexip-TZ Tablets is listed on the NAFDAC register under registration number A4-6072, and its registration is active as of 1 November 2026.

Has Trexip-TZ Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Trexip-TZ Tablets in our automatically synced alert list.

How can I check that my pack of Trexip-TZ Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-6072, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Trexip-TZ Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Corneal Ulcers: The recommended dosage regimen for the treatment of corneal ulcers is two drops into the affected eye every 15 minutes for the first six hours and then two drops into the affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third through the fourteenth day, place two drops in th…

What is Trexip-TZ Tablets used for?

Ciprofloxacin Ophthalmic Solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: Corneal Ulcers: Pseudomonas aeruginosa Serratia marcescens * Staphylococcus aureus Staphylococcus epidermidis Streptococcus pneumoniae Streptococcus (Viridans Group) * Conjunctivitis: Haemophilus influenzae Staphylococcus aure (Summarised from the official U.S. FDA label for ciprofloxacin (ciprofloxacin hydrochloride) and tinidazole. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Trexip-TZ Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.